Gene · 84061
Papers1,892
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 1,892
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| N-glycoproteomic and proteomic alterations in SRD5A3-deficient fibroblasts. | Glycobiology | 2024 | 39360848 | PubTator, text mining | PubMed |
| The Neuroprotective and Anxiolytic Effects of Magnesium Sulfate on Retinal Dopaminergic Neurons in 6-OHDA-Induced Parkinsonian Rats: A Pilot Study. | Brain Sci | 2024 | 39335357 | PubTator, text mining | PubMed |
| Targeting Death Receptor 5 (DR5) for the imaging and treatment of primary bone and soft tissue tumors: an update of the literature. | Front Mol Biosci | 2024 | 39286782 | PubTator, text mining | PubMed |
| XMEN-associated Systemic EBV-positive T-cell Lymphoma of Childhood: Report of Two Cases and Literature Review. | J Pediatr Hematol Oncol | 2024 | 39196630 | PubTator, text mining | PubMed |
| Genetic Testing in Patients with Autoimmune Lymphoproliferative Syndrome: Experience of 802 Patients at Cincinnati Children's Hospital Medical Center. | J Clin Immunol | 2024 | 39060684 | PubTator, text mining | PubMed |
| Ubiquitin recruiting chimera: more than just a PROTAC. | Biol Direct | 2024 | 38978100 | PubTator, text mining | PubMed |
| HLH and Recurrent EBV Lymphoma as the presenting manifestation of MAGT1 Deficiency: A Systematic Review of the Expanding Disease Spectrum. | J Clin Immunol | 2024 | 38896122 | PubTator, text mining | PubMed |
| XMEN disease caused by the novel MAGT1 p.(Trp136*) mutation may present with neuropsychiatric symptoms. | J Neuroimmunol | 2024 | 38878600 | PubTator, text mining | PubMed |
| Primary immune regulatory disorders (PIRD): expanding the mutation spectrum in Turkey and identification of sixteen novel variants. | Immunol Res | 2024 | 38644452 | PubTator, text mining | PubMed |
| Monozygotic Twins with MAGT1 Deficiency and Epstein-Barr virus-positive Classic Hodgkin Lymphoma Receiving anti-CD30 CAR T-cell Immunotherapy: A case Report. | J Clin Immunol | 2024 | 38578340 | PubTator, text mining | PubMed |
| Editorial: Hematopoietic stem cell transplantation: back to the future. | Front Med (Lausanne) | 2024 | 38562371 | PubTator, text mining | PubMed |
| Tonsillar cytotoxic CD4 T cells are involved in the control of EBV primary infection in children. | Sci Rep | 2024 | 38273012 | PubTator, text mining | PubMed |
| Label-free-based proteomic analysis reveals differential whey proteins of porcine milk during lactation. | Food Chem X | 2024 | 38268845 | PubTator, text mining | PubMed |
| Understanding the molecular mechanism of pathogenic variants of BIR2 domain in XIAP-deficient inflammatory bowel disease. | Sci Rep | 2024 | 38191507 | PubTator, text mining | PubMed |
| DCAF1-based PROTACs with activity against clinically validated targets overcoming intrinsic- and acquired-degrader resistance. | Nat Commun | 2024 | 38177131 | PubTator, text mining | PubMed |
| Genetic Risk Factors for Early-Onset Merkel Cell Carcinoma. | JAMA Dermatol | 2024 | 38170500 | PubTator, text mining | PubMed |
| Caffeic acid phenethyl ester: Unveiling its potential as a potent apoptosis inducer for combating hypopharyngeal squamous cell carcinoma. | Oncol Rep | 2024 | 38099422 | PubTator, text mining | PubMed |
| Adult-onset neurodegeneration in XMEN disease. | J Neuroimmunol | 2024 | 38041964 | PubTator, text mining | PubMed |
Model-Informed Selection of the Recommended Phase III Dose of the Inhibitor of Apoptosis Protein Inhibitor, Xevinapant, in Combination with Cisplatin and Concurrent Radiotherapy in Patients with Locally Advanced Squamous Cell Carcinoma of the Head and Neck. | Clin Pharmacol Ther | 2024 | 37777832 | PubTator, text mining | PubMed |
| Regulation of endogenous retroviruses in murine embryonic stem cells and early embryos. | J Mol Cell Biol | 2024 | 37604781 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/84061/papers?page=3